Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China · Delayed Price · Currency is CNY

18.59

+0.21 (1.14%)

Mar 10, 2026, 10:45 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
In Vitro Diagnostic Products and Solutions	220.14M	393.38M	9.97B	-	-
In Vitro Diagnostic Products and Solutions Growth	-44.04%	-96.05%	-	-	-
Third-Party Medical Testing	65.75M	297.96M	421.72M	115.00M	87.63M
Third-Party Medical Testing Growth	-77.93%	-29.35%	266.72%	31.24%	1352.18%
Agency Business	64.17M	58.20M	137.17M	135.08M	67.34M
Agency Business Growth	10.25%	-57.57%	1.54%	100.59%	9936.41%
in Vitro Diagnostic Reagent	-	-	-	2.47B	781.81M
in Vitro Diagnostic Reagent Growth	-	-	-	216.11%	383.56%
in Vitro Diagnostic Equipment	-	-	-	24.93M	12.88M
in Vitro Diagnostic Equipment Growth	-	-	-	93.53%	186.76%
Emergency and Critical Care Information Solutions	-	-	-	39.00M	9.44M
Emergency and Critical Care Information Solutions Growth	-	-	-	313.16%	-
Others	-	-	-	44.45M	-
Total	350.06M	749.54M	10.53B	2.83B	959.10M
Total Growth	-53.30%	-92.88%	272.12%	195.05%	429.43%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Northeast China	4.37M	62.47M	844.97M	271.16M	100.66M
Northeast China Growth	-93.00%	-92.61%	211.61%	169.37%	1226.78%
North China	13.89M	26.55M	713.21M	214.87M	58.58M
North China Growth	-47.70%	-96.28%	231.93%	266.81%	535.07%
Eastern China	21.52M	61.98M	3.03B	462.07M	91.97M
Eastern China Growth	-65.28%	-97.96%	556.01%	402.43%	190.94%
Southern China	79.89M	348.19M	1.76B	479.66M	156.22M
Southern China Growth	-77.05%	-80.19%	266.36%	207.04%	602.76%
Central	104.95M	98.33M	1.49B	329.75M	241.34M
Central Growth	6.73%	-93.39%	351.43%	36.64%	409.01%
Northwestern	84.77M	121.72M	2.08B	700.97M	207.90M
Northwestern Growth	-30.36%	-94.15%	196.66%	237.18%	346.50%
Southwest	11.56M	19.52M	317.26M	122.28M	17.11M
Southwest Growth	-40.80%	-93.85%	159.45%	614.54%	5.88%
Overseas	29.12M	10.78M	298.25M	249.07M	85.33M
Overseas Growth	170.11%	-96.39%	19.75%	191.90%	23127.63%
Total	350.06M	749.54M	10.53B	2.83B	959.10M
Total Growth	-53.30%	-92.88%	272.12%	195.05%	429.43%

Source: S&P Global Market Intelligence.